AstraZeneca Hopes To Save FluMist In US With Foreign Data
This article was originally published in The Pink Sheet Daily
Executive Summary
After a CDC advisory committee recommends against the nasal flu vaccine's use in any setting, sponsor AstraZeneca looks to reconcile its effectiveness results with government findings.